Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 15c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.72), $0.15 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $630 thousand versus the consensus estimate of $4.35 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• eBay (EBAY) call put ratio 1 call 3.6 puts with a focus on 5200 contracts of October 9 weekly 108 puts
• McDonald's (MCD) Said August In Us Business Was 'slightly Negative' - Bloomberg